STAT+: Masimo’s CEO on battling Apple for the health wearable market
It’s been a chaotic three years for Masimo CEO Joe Kiani. First came the pandemic,…
Category: Medicine
‘Stunning’ change to United’s colonoscopy coverage roils physicians and patients
When gastroenterologists learned in March that UnitedHealthcare plans to barricade many colonoscopies behind a controversial…
STAT+: FDA advisory panel narrowly recommends approval for Sarepta’s gene therapy for Duchenne
For an archived version of a live blog about Friday’s FDA advisory panel hearing, click…
From fusion to retooling cancer trials, Eric Lander wants his new group to ‘go after big problems’
Throughout his storied career, Eric Lander has led science projects in just about every setting…
STAT+: Pharmalittle: U.S. Senate committee passes PBM bills; Pfizer CEO predicts pharma will sue over Medicare price negotiations
And so, another working week will soon draw to a close. Not a moment too…
A physician’s Mother’s Day gift: reclaimed time with my children — and for myself
As a child, I fondly remember running through the kids’ aisle at Video World with…
Tracking the FDA advisory panel on Sarepta’s gene therapy for Duchenne muscular dystrophy
The Food and Drug Administration is convening a meeting of outside experts on Friday to…
An ultrasound device may unlock brain cancer treatment, early study shows
Brain cancer patients are left with few options when tumor cells spread, as most potent…
Opinion: Proposed rules to protect health data in an era of abortion bans fall short
When the Supreme Court overturned Roe v. Wade, it effectively rescinded national protections of reproductive…
.jpg)
R.J. Reynolds sues California to protect ‘crisp’ cigarettes from flavor ban
WASHINGTON – Tobacco giant R.J. Reynolds is suing the state of California in an effort…
STAT+: AbbVie sues a behind-the-scenes company for exploiting its patient assistance program
AbbVie has filed a lawsuit against a behind-the-scenes company that helps health plan sponsors take…
STAT+: Senate panel passes a suite of drug pricing bills — but fails to advance one major PBM reform
WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at…
Listen: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
Is there a Bermuda Triangle of drug prices? Do FDA advisers matter? And when should…
Key House Democrat demands NIH answer for pace of long Covid research
WASHINGTON — A powerful Democratic lawmaker is interrogating the National Institutes of Health over its…
A former health insurance executive turns to tech to make claims less of a nightmare
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Scientists use ‘mini-brains’ to study microglia, the brain’s cleanup crew and key players in neurological disease
Home to billions of cells that form trillions of connections, the human brain isn’t just…
WHO ends global health emergency over mpox
The World Health Organization ended the global health emergency for mpox on Thursday, saying that…
STAT+: Wyden decries ‘astonishingly low’ tax rates for pharma companies as he probes business maneuvers
Thanks to changes in tax law six years ago, several of the largest pharmaceutical companies…
STAT+: Pharmalittle: FDA panel recommends first OTC birth control pill; Senate hearing on insulin costs satisfies no one
Hello, everyone, and how are you today? We are doing just fine, thank you, as…
STAT+: How the FDA’s pandemic flexibilities boosted mental health apps — and what happens now
In April 2020, the Food and Drug Administration announced a pandemic enforcement policy allowing mental…
STAT+: Telework helps FDA compete for scientists. What if it’s no longer an option?
WASHINGTON — The Food and Drug Administration needs to hire scores of in-demand scientists, and…
Opinion: Fear-based messaging doesn’t stop drug use. But it does make things worse
It “rots” flesh. It “tears” bone. It will turn you into a “zombie.” According to…
“I don’t see this as an end to the pandemic”: Ashish Jha on the end of Covid public health emergency
On the eve of the expiration date for the federally declared coronavirus public health emergency,…
STAT+: Lawmakers press CMS to release new breakthrough device coverage rule
WASHINGTON — An array of lawmakers called for a simpler reimbursement pathway for breakthrough devices…
STAT+: Insulin makers, PBMs echo old finger-pointing in Senate hearing
A Senate hearing on high insulin costs billed as a blockbuster showdown with drugmakers and…
STAT+: Skin patch for toddlers with peanut allergy shows promising results in late-stage trial
Parents of kids who have peanut allergies have to practice constant vigilance, whether that means…
Black patients far less likely to receive key opioid addiction medication, study finds
Black people are far less likely than other Americans to receive buprenorphine, a key medication…
Ask STAT: What do you want to know about ChatGPT in medicine?
From medical note-taking to analyzing X-rays and mammograms, new artificial intelligence tools are swiftly gaining…
FDA panel votes in favor of the first-ever over-the-counter birth control pill
In a highly significant move, a panel of independent experts on Wednesday voted unanimously that…
STAT+: Google is training its generative AI to analyze medical images — and talk to doctors about them
Google’s generative AI system proved it can answer medical exam questions. But now the company…
Human ‘pangenome’ published, with goal of making genomics more useful for diverse populations
An international team of scientists has assembled the first human “pangenome” — an attempt to…
STAT+: Pharmalittle: Gilead wins lawsuit against HHS over HIV pill patents; most Americans say abortion pill should remain on the market
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: FDA reviewers had string of concerns about Sarepta’s gene therapy for Duchenne, documents show
Reviewers at the Food and Drug Administration concluded that Sarepta Therapeutics did not show that…
STAT+: Brigham creates institute focused on immunology with record $100 million gift
Brigham and Women’s Hospital will launch a new institute focused on immunology and inflammation, thanks…
Opinion: Three misconceptions about the accelerated drug approval pathway
On Friday, the Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee will…
Opinion: Listen: The coercion built into medical privacy consent forms
Alex Rosenblat is particularly careful when it comes to her digital privacy. She requests to…
STAT+: In small study, weight loss drug boosts immune cells that help fight cancer
Drugs like Ozempic and Wegovy have become immensely popular for their ability to help people…
Opinion: The tragedy of the Golden Gate Bridge’s $400 million anti-suicide net
Each year about 30 people make the gut-wrenching decision to leap off the Golden Gate…
Why health care needs to shift its thinking on AI, FDA’s health tech progress, & the latest on Carbon’s insurance dust-up
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Who’s in charge of the White House Covid response after the emergency ends?
WASHINGTON — The White House isn’t quite ready to launch its new pandemic response office…
STAT+: What FDA mandate? Sun Pharma halts shipments from a plant with a troubled history
In a fresh sign of quality-control problems in the Indian pharmaceutical industry, the U.S. Food…
STAT+: Gilead defeats federal government in closely watched battle over patents for HIV prevention pills
A U.S. court jury handed a major win to Gilead Sciences on Tuesday in a…
Breast cancer screening should begin at 40, not 50, federal health panel recommends
The United States Preventive Services Task Force on Tuesday created new guidelines recommending all women…
STAT+: Pharmalittle: Big pharma maps legal strategy against U.S. drug pricing reform; U.S. pharma layoffs continue to climb
Top of the morning to you, and a fine one it is. The sun is…
.jpg)
STAT+: What to know about a pivotal FDA hearing on Sarepta’s gene therapy for Duchenne
On Friday, a committee of advisers to the Food and Drug Administration will meet to…
STAT+: Q&A: Sen. Sanders on insulin costs and his committee’s generic drug kerfuffle
WASHINGTON — Wednesday’s Senate hearing on high costs for insulin “is not the end” of…
STAT+: ‘Hard to catch up’: FDA commissioner on regulating new digital health tools
WASHINGTON — Digital health tools are developing faster than the Food and Drug Administration is able…
Opinion: The IRA’s nonsensical distinction between small- and large-molecule drugs
Thanks to advances in science, notably the completion of the Human Genome Project 20 years…
An artist uses the canvas to make sense of her partner’s illness, and her own
For Lauryn Welch, a 32-year-old artist with roots in New Hampshire, painting and chronic illness…
Opinion: Health care coaches are the next big thing. They’re also completely unregulated
John, a hypothetical middle-aged man, is told at his job about a new workplace wellness…